Mater researchers receive generous support to improve the health of preterm babies and reduce the rate of stillbirth across the country.

A Queensland-first trial that will assess the impacts of COVID-19 on expectant parents and their unborn babies, at Mater Mothers’ Hospitals, supported by the Lott, via Golden Casket.

Results from the Ridstress trial show there is close to a 50 per cent reduction in women requiring an emergency caesarean or a forceps delivery for fetal distress when they take Sildenafil in labour.